CARE

National Medical Care Co.

4005StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operating Summary
Revenue	1.60B	1.29B	1.08B	0.92B	0.85B
Cost of Revenue	1.02B	0.85B	0.71B	0.63B	0.60B
Gross Profit	582.88M	445.70M	366.85M	286.95M	244.30M
SG&A	211.97M	168.23M	124.53M	93.08M	79.09M
Operating Expenses	228.34M	194.62M	120.13M	89.68M	79.90M
Operating Income	354.54M	251.08M	246.72M	197.27M	164.40M
Interest Income	18.80M	19.48M	21.37M	1.24M	—
Interest Expense	-26.97M	-22.74M	-3.50M	—	—
Pretax Income	346.36M	290.16M	264.59M	198.50M	164.40M
Income Tax	27.89M	-4.54M	23.67M	28.43M	28.04M
Net Income	318.47M	294.70M	240.93M	170.07M	136.36M
EBITDA	437.75M	315.14M	290.94M	239.17M	214.56M
EBIT	354.54M	251.08M	246.72M	197.27M	164.40M
EPS (Basic)	7.13	6.58	5.37	3.79	3.04
EPS (Diluted)	7.13	6.58	5.37	3.79	3.04
DPS	3.00	2.00	2.00	1.00	1.00
Margins & Efficiency
Gross Margin %	+36.4%	+34.5%	+33.9%	+31.3%	+28.9%
EBITDA Margin %	+27.4%	+24.4%	+26.9%	+26.1%	+25.4%
Net Margin %	+19.9%	+22.8%	+22.3%	+18.5%	+16.1%
Revenue & Income
Revenue	1.60B	1.29B	1.08B	0.92B	0.85B
Revenue Growth (YoY)	+23.7%	+19.6%	+17.9%	+8.6%	+4.5%
Interest & Investment Income	18.80M	19.48M	21.37M	1.24M	—
Expenses & Provisions
Cost of Revenue	1.02B	0.85B	0.71B	0.63B	0.60B
Selling, General & Admin	211.97M	168.23M	124.53M	93.08M	79.09M
Operating Expenses	228.34M	194.62M	120.13M	89.68M	79.90M
Other Operating Expenses	-1.40M	-6.33M	-4.03M	-8.35M	-8.19M
Interest Expense	-26.97M	-22.74M	-3.50M	—	—
Legal Settlements	—	42.34M	—	—	—
D&A For EBITDA	83.21M	64.06M	44.22M	41.90M	50.16M
Profitability & Returns
Gross Profit	582.88M	445.70M	366.85M	286.95M	244.30M
Gross Margin	+36.4%	+34.5%	+33.9%	+31.3%	+28.9%
EBIT	354.54M	251.08M	246.72M	197.27M	164.40M
EBIT Margin	+22.2%	+19.4%	+22.8%	+21.5%	+19.4%
EBITDA	437.75M	315.14M	290.94M	239.17M	214.56M
EBITDA Margin	+27.4%	+24.4%	+26.9%	+26.1%	+25.4%
EBT Excluding Unusual Items	346.36M	247.83M	264.59M	198.50M	164.40M
Pretax Income	346.36M	290.16M	264.59M	198.50M	164.40M
Operating Income	354.54M	251.08M	246.72M	197.27M	164.40M
Operating Margin	+22.2%	+19.4%	+22.8%	+21.5%	+19.4%
Profit Margin	+19.9%	+22.8%	+22.3%	+18.5%	+16.1%
Net Income	318.47M	294.70M	240.93M	170.07M	136.36M
Net Income to Common	318.47M	294.70M	240.93M	170.07M	136.36M
Net Income Growth	+8.1%	+22.3%	+41.7%	+24.7%	+40.2%
Income Tax Expense	27.89M	-4.54M	23.67M	28.43M	28.04M
Effective Tax Rate	+8.1%	—	+8.9%	+14.3%	+17.1%
Per Share & Capital
EPS (Basic)	7.13	6.58	5.37	3.79	3.04
EPS (Diluted)	7.13	6.58	5.37	3.79	3.04
EPS Growth	+8.3%	+22.5%	+41.7%	+24.7%	+40.2%
Dividend Per Share	3.00	2.00	2.00	1.00	1.00
Shares Change (YoY)	-0	-0	—	—	—
Shares Outstanding (Basic)	44.69M	44.77M	44.85M	44.85M	44.85M
Shares Outstanding (Diluted)	44.69M	44.77M	44.85M	44.85M	44.85M
Dividend Growth	+50.0%	—	+100.0%	—	—
Free Cash Flow	26.80M	136.63M	412.73M	185.83M	61.61M
Free Cash Flow Margin	+1.7%	+10.6%	+38.2%	+20.2%	+7.3%
Free Cash Flow Per Share	0.60	3.05	9.20	4.14	1.37
Payout Ratio	+28.1%	+30.4%	+18.6%	+26.4%	+32.9%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operating Summary
Revenue	1.60B	1.29B	1.08B	0.92B	0.85B
Cost of Revenue	1.02B	0.85B	0.71B	0.63B	0.60B
Gross Profit	582.88M	445.70M	366.85M	286.95M	244.30M
SG&A	211.97M	168.23M	124.53M	93.08M	79.09M
Operating Expenses	228.34M	194.62M	120.13M	89.68M	79.90M
Operating Income	354.54M	251.08M	246.72M	197.27M	164.40M
Interest Income	18.80M	19.48M	21.37M	1.24M	—
Interest Expense	-26.97M	-22.74M	-3.50M	—	—
Pretax Income	346.36M	290.16M	264.59M	198.50M	164.40M
Income Tax	27.89M	-4.54M	23.67M	28.43M	28.04M
Net Income	318.47M	294.70M	240.93M	170.07M	136.36M
EBITDA	437.75M	315.14M	290.94M	239.17M	214.56M
EBIT	354.54M	251.08M	246.72M	197.27M	164.40M
EPS (Basic)	7.13	6.58	5.37	3.79	3.04
EPS (Diluted)	7.13	6.58	5.37	3.79	3.04
DPS	3.00	2.00	2.00	1.00	1.00
Margins & Efficiency
Gross Margin %	+36.4%	+34.5%	+33.9%	+31.3%	+28.9%
EBITDA Margin %	+27.4%	+24.4%	+26.9%	+26.1%	+25.4%
Net Margin %	+19.9%	+22.8%	+22.3%	+18.5%	+16.1%
Revenue & Income
Revenue	1.60B	1.29B	1.08B	0.92B	0.85B
Revenue Growth (YoY)	+23.7%	+19.6%	+17.9%	+8.6%	+4.5%
Interest & Investment Income	18.80M	19.48M	21.37M	1.24M	—
Expenses & Provisions
Cost of Revenue	1.02B	0.85B	0.71B	0.63B	0.60B
Selling, General & Admin	211.97M	168.23M	124.53M	93.08M	79.09M
Operating Expenses	228.34M	194.62M	120.13M	89.68M	79.90M
Other Operating Expenses	-1.40M	-6.33M	-4.03M	-8.35M	-8.19M
Interest Expense	-26.97M	-22.74M	-3.50M	—	—
Legal Settlements	—	42.34M	—	—	—
D&A For EBITDA	83.21M	64.06M	44.22M	41.90M	50.16M
Profitability & Returns
Gross Profit	582.88M	445.70M	366.85M	286.95M	244.30M
Gross Margin	+36.4%	+34.5%	+33.9%	+31.3%	+28.9%
EBIT	354.54M	251.08M	246.72M	197.27M	164.40M
EBIT Margin	+22.2%	+19.4%	+22.8%	+21.5%	+19.4%
EBITDA	437.75M	315.14M	290.94M	239.17M	214.56M
EBITDA Margin	+27.4%	+24.4%	+26.9%	+26.1%	+25.4%
EBT Excluding Unusual Items	346.36M	247.83M	264.59M	198.50M	164.40M
Pretax Income	346.36M	290.16M	264.59M	198.50M	164.40M
Operating Income	354.54M	251.08M	246.72M	197.27M	164.40M
Operating Margin	+22.2%	+19.4%	+22.8%	+21.5%	+19.4%
Profit Margin	+19.9%	+22.8%	+22.3%	+18.5%	+16.1%
Net Income	318.47M	294.70M	240.93M	170.07M	136.36M
Net Income to Common	318.47M	294.70M	240.93M	170.07M	136.36M
Net Income Growth	+8.1%	+22.3%	+41.7%	+24.7%	+40.2%
Income Tax Expense	27.89M	-4.54M	23.67M	28.43M	28.04M
Effective Tax Rate	+8.1%	—	+8.9%	+14.3%	+17.1%
Per Share & Capital
EPS (Basic)	7.13	6.58	5.37	3.79	3.04
EPS (Diluted)	7.13	6.58	5.37	3.79	3.04
EPS Growth	+8.3%	+22.5%	+41.7%	+24.7%	+40.2%
Dividend Per Share	3.00	2.00	2.00	1.00	1.00
Shares Change (YoY)	-0	-0	—	—	—
Shares Outstanding (Basic)	44.69M	44.77M	44.85M	44.85M	44.85M
Shares Outstanding (Diluted)	44.69M	44.77M	44.85M	44.85M	44.85M
Dividend Growth	+50.0%	—	+100.0%	—	—
Free Cash Flow	26.80M	136.63M	412.73M	185.83M	61.61M
Free Cash Flow Margin	+1.7%	+10.6%	+38.2%	+20.2%	+7.3%
Free Cash Flow Per Share	0.60	3.05	9.20	4.14	1.37
Payout Ratio	+28.1%	+30.4%	+18.6%	+26.4%	+32.9%